Khuller et al., 2021 - Google Patents
MFSD2A-associated primary microcephaly-Expanding the clinical and mutational spectrum of this ultra-rare diseaseKhuller et al., 2021
- Document ID
- 8878231319313600408
- Author
- Khuller K
- Yigit G
- Grijalva C
- Altmueller J
- Thiele H
- Nürnberg P
- Elcioglu N
- Yeter B
- Hehr U
- Stein A
- Della Marina A
- Koeninger A
- Depienne C
- Kaiser F
- Wollnik B
- Kuechler A
- Publication year
- Publication venue
- European Journal of Medical Genetics
External Links
Snippet
MFSD2A, a member of the major facilitator superfamily (MFS), is a transmembrane transporter responsible for the uptake of specific essential fatty acids through the blood-brain barrier (BBB) to the brain. The transporter is crucial for early embryonic brain development …
- 101710026796 MFSD2A 0 title abstract description 94
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11096956B2 (en) | Antisense oligomers and uses thereof | |
| Notaras et al. | The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy | |
| Oláhová et al. | LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population | |
| Kara et al. | Genetic and phenotypic characterization of complex hereditary spastic paraplegia | |
| Zaharieva et al. | Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or ‘classical’congenital myopathy | |
| Balreira et al. | ANO10 mutations cause ataxia and coenzyme Q10 deficiency | |
| Hirata et al. | ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticity | |
| Bonora et al. | Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy | |
| Feichtinger et al. | Biallelic variants in the transcription factor PAX7 are a new genetic cause of myopathy | |
| Zanni et al. | A novel mutation in the endosomal Na+/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES) | |
| Sambuughin et al. | Adult-onset autosomal dominant spastic paraplegia linked to a GTPase-effector domain mutation of dynamin 2 | |
| Suleiman et al. | WDR45B‐related intellectual disability, spastic quadriplegia, epilepsy, and cerebral hypoplasia: a consistent neurodevelopmental syndrome | |
| Khuller et al. | MFSD2A-associated primary microcephaly-Expanding the clinical and mutational spectrum of this ultra-rare disease | |
| Jørgensen et al. | Vascular Ehlers–Danlos syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family | |
| Sheffer et al. | Biallelic variants in AGTPBP1, involved in tubulin deglutamylation, are associated with cerebellar degeneration and motor neuropathy | |
| Tabares-Seisdedos et al. | Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study | |
| Liao et al. | SPG35 contributes to the second common subtype of AR‐HSP in China: frequency analysis and functional characterization of FA2H gene mutations | |
| Kaiyrzhanov et al. | Defective phosphatidylethanolamine biosynthesis leads to a broad ataxia-spasticity spectrum | |
| De Pace et al. | Biallelic BORCS8 variants cause an infantile-onset neurodegenerative disorder with altered lysosome dynamics | |
| Kettwig et al. | Compound heterozygous variants in PGAP1 causing severe psychomotor retardation, brain atrophy, recurrent apneas and delayed myelination: a case report and literature review | |
| Guasto et al. | Biallelic variants in SLC35B2 cause a novel chondrodysplasia with hypomyelinating leukodystrophy | |
| Ge et al. | Recessive mutations in proximal I-band of TTN gene cause severe congenital multi-minicore disease without cardiac involvement | |
| Häusler et al. | A novel homozygous splice-site mutation in the SPTBN4 gene causes axonal neuropathy without intellectual disability | |
| Zhao et al. | First report of paternal uniparental disomy of chromosome 8 with SLC52A2 mutation in Brown-vialetto-van laere syndrome type 2 and an analysis of genotype-phenotype correlations | |
| Burke et al. | Compound heterozygous KCTD7 variants in progressive myoclonus epilepsy |